Cargando…
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in Italy
BACKGROUND: Epidemiological evidence suggests that anti-inflammatory and immunomodulatory properties of statins may reduce the risk of infections and infection-related complications. OBJECTIVE: We aimed to assess the impact of prior statin use on coronavirus disease (COVID-19) severity and mortality...
Autores principales: | Mitacchione, Gianfranco, Schiavone, Marco, Curnis, Antonio, Arca, Marcello, Antinori, Spinello, Gasperetti, Alessio, Mascioli, Giosuè, Severino, Paolo, Sabato, Federica, Caracciolo, Maria M., Arabia, Gianmarco, D'Erasmo, Laura, Viecca, Maurizio, Mancone, Massimo, Galli, Massimo, Forleo, Giovanni B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Lipid Association.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833194/ https://www.ncbi.nlm.nih.gov/pubmed/33390341 http://dx.doi.org/10.1016/j.jacl.2020.12.008 |
Ejemplares similares
-
Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience
por: Schiavone, Marco, et al.
Publicado: (2021) -
Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease
por: Schiavone, Marco, et al.
Publicado: (2020) -
Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties
por: Schiavone, Marco, et al.
Publicado: (2020) -
Quis custodiet ipsos custodes: are we taking care of healthcare workers in the Italian COVID-19 outbreak?
por: Schiavone, M., et al.
Publicado: (2020) -
Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19
por: Schiavone, Marco, et al.
Publicado: (2022)